Add Natco Pharma Ltd., target Rs 585.0 : Dr CK Narayan
Add Natco Pharma Ltd. at a price target of Rs 585.012-09-2016
12-09-2016
NATCOs marketing partner Mylan Invalidates Third Teva Copaxone 40 mg/mL Patent Via U.S. Patent and Trademark Office's Inter Partes Review Proceeding
Natco Pharma Ltd has informed BSE regarding a Press Release dated September 02, 2016 titled "NATCOs marketing partner Mylan Invalidates Third Teva Copaxone 40 mg/mL Patent Via U.S. Patent and Trademark Office's Inter Partes Review Proceeding".02-09-2016
Buy Natco Pharma Ltd., target Rs 780.0 : Avinash Gorakshakar
If the molecules which are in the pipeline for the US market get developed faster, the company could see a big run up30-08-2016
NATCO's marketing partner Mylan Invalidates Two of Teva's Copaxone 40 mg/mL Patents Via U.S. Patent and Trademark Office's Inter Partes Review Proceeding
Natco Pharma Ltd has submitted to BSE a copy of Press Release dated August 25, 2016 titled ''NATCO's marketing partner Mylan Invalidates Two of Teva's Copaxone 40 mg/mL Patents Via U.S. Patent and Trademark Office's Inter Partes Review Proceeding".25-08-2016
Torrent, Natco, Sun are top pharma picks: Nischal Maheshwari, Edelweiss Securities
One cannot be positive on the whole pharma sector. One has to be very, very stock specific25-08-2016
Natco Pharma zooms on EIR for Chennai facility
The stock moved higher to its fresh lifetime high of Rs 703, up 7% on the National Stock Exchange.25-08-2016
Natco receives establishment inspection report for chennai facility
Natco Pharma Ltd has submitted to BSE a copy of Press Release dated August 25, 2016 titled 'Natco receives establishment inspection report for chennai facility'25-08-2016
Natco Pharma shares gain after USFDA clearance for Kothur plant
Analysts said the successful closure of USFDA inspection at Natco's Kothur facility is critical for the company's impending big launches16-08-2016
Natco receives Establishment Inspection Report for Kothur Facility
Natco Pharma Ltd has informed BSE regarding a Press Release dated August 16, 2016 titled "Natco receives Establishment Inspection Report for Kothur Facility".16-08-2016
Buy Natco Pharma., target Rs 690 : Shrikant Chouhan
Buy Natco Pharma Ltd. at a price target of Rs 690.0 and a stop loss at Rs 610.0 from entry point12-08-2016